Monoclonal gammopathy
ICD-10 D47.2 is a billable code used to indicate a diagnosis of monoclonal gammopathy.
Monoclonal gammopathy refers to a condition characterized by the presence of an abnormal protein (monoclonal protein or M-protein) in the blood, produced by a clone of plasma cells. This condition is often detected incidentally during routine blood tests and can be associated with various underlying disorders, including multiple myeloma, Waldenström's macroglobulinemia, and other lymphoproliferative disorders. Monoclonal gammopathy is classified as a neoplasm of uncertain behavior, meaning that while it may not be immediately life-threatening, it has the potential to progress to more serious conditions. Surveillance is crucial, as some patients may develop complications or progress to malignancy over time. Regular monitoring of serum protein electrophoresis and immunofixation tests is recommended to assess changes in the monoclonal protein levels. The clinical management of monoclonal gammopathy involves a multidisciplinary approach, including hematology and oncology specialists, to determine the appropriate follow-up and intervention strategies based on individual risk factors and clinical presentation.
Detailed patient history, laboratory results, and follow-up plans.
Patients presenting with elevated protein levels, routine monitoring of known cases.
Ensure accurate documentation of any progression to malignancy or related conditions.
Comprehensive treatment plans, response to therapy, and any complications.
Management of patients with progression to multiple myeloma or other malignancies.
Document any treatment interventions and their outcomes.
Used to confirm the presence of monoclonal protein in patients with suspected gammopathy.
Document the indication for the test and any relevant clinical findings.
Hematology specialists should ensure that the test results are correlated with clinical symptoms.
Monoclonal gammopathy is a condition characterized by the presence of abnormal proteins in the blood, which may or may not progress to multiple myeloma, a malignant condition. Diagnosis and management depend on clinical findings and laboratory results.
